Analysis Tools|
Allele Symbol Allele Name Allele ID |
Tg(Nphs2-cre)1Seq transgene insertion 1, Susan E Quaggin MGI:3586451 |
||||||||||||||||||||||||||||||||||||
| Summary |
8 genotypes
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• with loss of filtration slits
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• by 4 days of age, mutants are smaller than wild-type littermates; this is more apparent by 3 weeks of age
|
|
• at 3.5 and 4.5 weeks of age, mutants show excessive amounts of albumin in their urine, indicating damage to the filtration barrier
|
|
• at 3.5 and 4.5 weeks of age, mutants show excessive amounts of albumin in their urine, indicating damage to the filtration barrier
|
|
• by 3.5 weeks of age, loss of podocytes is observed
|
|
• at E16.5, differentiated foot processes are absent in mutant embryos
|
|
• in 4-day old mutants, there is complete fusion of foot processes around the capillary loops of the glomeruli
|
|
• by 3.5 weeks of age, focal sclerosis and other defects are observed in the glomeruli
|
|
• by 3.5 weeks of age, focal sclerosis is observed in the glomeruli
|
|
• mutants have a buildup of proteinaceous material in the kidney tubules
|
|
• damaged glomerular filtration barrier
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• significantly increased urinary protein to creatinine ratio in affected mice
• streptozotocin induced diabetes at 17 weeks of age in protected cohort results in increased urinary protein to creatinine ratio
|
|
• massive proteinuria in 40% of mice by 5 weeks of age
• 60& of mice do not develop proteinuria through 8 months of age
• in protected cohort of mice proteinuria development resumes after 32 weeks of age
• streptozotocin induced diabetes at 17 weeks of age in protected cohort results in massive proteinuria
|
|
• dynamic proliferation of cells in Bowman's capsule
|
|
• occasional podocyte vacuolation
• focal flattening and disorganized foot processes in all mice
|
|
• extensive effacement in affected mice with large bumpy subepithelial protrusions of the glomerular basement membrane
• prominent fibrinogen depositions
|
|
• simplified glomerular structure at birth and at 3 weeks of age
• total cell number reduced by 15%
• non-podocyte cell number reduced 25%
|
|
• focal and segmental glomerulosclerosis with occasional crescent formation and podocyte vacuolation
• streptozotocin induced diabetes at 17 weeks of age in protected cohort results in dramatic glomerulosclerosis
|
|
• with an irregular surface in affected mice
|
|
• in affected mice
|
|
• end stage renal disease in some mice with death at 3-6 weeks of age
|
|
• significantly increased urinary protein to creatinine ratio in affected mice
• streptozotocin induced diabetes at 17 weeks of age in protected cohort results in increased urinary protein to creatinine ratio
|
|
• massive proteinuria in 40% of mice by 5 weeks of age
• 60& of mice do not develop proteinuria through 8 months of age
• in protected cohort of mice proteinuria development resumes after 32 weeks of age
• streptozotocin induced diabetes at 17 weeks of age in protected cohort results in massive proteinuria
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice exhibit normal podocyte development and kidney function
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice exhibit normal podocyte development and kidney function
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
| N |
• mice do not show albuminuria or glomerular abnormalities
• mice show a similar level of nephropathy as wild-type mice when treated with streptozotocin (STZ) to induce diabetes
|
|
• podocytes are partially protected against protamine sulfate-induced foot process effacement
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• growth restriction observed starting around 4 weeks of age
• no overt phenotypes until after 3 weeks of age
|
|
• protein/creatinine ratio is significantly increased at 3 weeks of age
|
|
• protein/creatinine ratio is significantly increased at 3 weeks of age
|
|
• distended Bowman's space at 5 weeks
|
|
• numerous vacuolated podocytes at 4 weeks of age
• widespread vacuolation of podocytes at 5 weeks of age
|
|
• focal effacement at 3 weeks of age but endothelium and glomerular basement membranes are preserved
|
|
• areas of sclerosis at 4 weeks of age
• complete destruction of glomerular tuft at 5 weeks of age
|
|
• proteinaceous casts found in tubules of 2-3 week old mice
|
|
• autophagosomal vesicles accumulate in podocytes beginning at 2 weeks of age
|
|
|
| ♀ | phenotype observed in females |
| ♂ | phenotype observed in males |
| N | normal phenotype |
|
• administration of doxycycline in the drinking water to 4 month old mice and consequent VEGF-A164 expression in podocyte of glomerulus caused proteinuria after 7 days of treatment
|
|
• administration of doxycycline in the drinking water to 4 month old mice and consequent VEGF-A164 expression in podocyte of glomerulus caused proteinuria after 7 days of treatment
|
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO) |
||
|
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support. |
last database update 11/19/2024 MGI 6.24 |
|
|
|
||
